Literature DB >> 2030509

Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma.

F A Moore1, E E Moore, R Poggetti, O J McAnena, V M Peterson, C M Abernathy, P E Parsons.   

Abstract

Animal studies implicate gut bacterial translocation via the portal vein as a major factor in the pathogenesis of postinjury multiple organ failure (MOF). We therefore inserted portal vein catheters for sequential blood sampling in the operating room, at 6, 12, 24, and 48 hours, and 5 days postoperatively in 20 injured patients (13 blunt, seven penetrating; mean age, 34 years) requiring emergent laparotomy and who were at known risk for MOF. The mean Revised Trauma Score was 6.4 +/- 0.4, and the Injury Severity Score, 29.3 +/- 2.3. Twelve (60%) patients arrived in shock (SBP less than 90 torr). Eight (2%) of 212 portal blood cultures were positive; seven were presumed contaminants. The only positive systemic culture (total, 212) was a Staphylococcus aureus on day 5 in a patient with a concurrent staphyloccal pneumonia. In the first 48 hours, we could not detect endotoxin in portal or systemic blood. Additionally, simultaneous portal and systemic blood levels of complement fragment C3a, tumor necrosis factor, and interleukin-6 were nearly identical and, specifically, were not different in those patients who developed MOF. In summary, this prospective clinical study has not confirmed portal or systemic bacteremia within the first 5 days postinjury, despite an eventual 30% incidence of MOF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2030509     DOI: 10.1097/00005373-199105000-00006

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  86 in total

1.  Bacterial translocation as a cause of septic shock in humans: a report of two cases.

Authors:  T Tani; K Hanasawa; Y Endo; Y Kurumi; H Shiomi; M Kodama; R Kushima; T Hattori
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

Review 2.  Nosocomial pneumonia in the intensive care unit: mechanisms and significance.

Authors:  C A'Court; C S Garrard
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

3.  Guidelines for enteral feeding in adult hospital patients.

Authors:  M Stroud; H Duncan; J Nightingale
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

4.  Early complementopathy after multiple injuries in humans.

Authors:  Anne-Maud Burk; Myriam Martin; Michael A Flierl; Daniel Rittirsch; Matthias Helm; Lorenz Lampl; Uwe Bruckner; Gregory L Stahl; Anna M Blom; Mario Perl; Florian Gebhard; Markus Huber-Lang
Journal:  Shock       Date:  2012-04       Impact factor: 3.454

Review 5.  The gastrointestinal immune system: Implications for the surgical patient.

Authors:  Joseph F Pierre; Rebecca A Busch; Kenneth A Kudsk
Journal:  Curr Probl Surg       Date:  2015-10-23       Impact factor: 1.909

Review 6.  The microbiome and critical illness.

Authors:  Robert P Dickson
Journal:  Lancet Respir Med       Date:  2015-12-12       Impact factor: 30.700

Review 7.  Persistent Inflammation, Immunosuppression, and Catabolism: Evolution of Multiple Organ Dysfunction.

Authors:  Martin D Rosenthal; Frederick A Moore
Journal:  Surg Infect (Larchmt)       Date:  2015-12-21       Impact factor: 2.150

Review 8.  Gut-origin sepsis: evolution of a concept.

Authors:  Edwin A Deitch
Journal:  Surgeon       Date:  2012-04-23       Impact factor: 2.392

9.  Impact of the method of initial stabilization for femoral shaft fractures in patients with multiple injuries at risk for complications (borderline patients).

Authors:  Hans-Christoph Pape; Dieter Rixen; John Morley; Elisabeth Ellingsen Husebye; Michael Mueller; Clemens Dumont; Andreas Gruner; Hans Joerg Oestern; Michael Bayeff-Filoff; Christina Garving; Dustin Pardini; Martijn van Griensven; Christian Krettek; Peter Giannoudis
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

10.  Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock.

Authors:  L J Magnotti; J S Upperman; D Z Xu; Q Lu; E A Deitch
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.